Company Filing History:
Years Active: 2018
Title: Michal Schwartz-Eisenbach: Innovator in Peptide Research
Introduction
Michal Schwartz-Eisenbach is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of peptide research, particularly in the development of modified kisspeptin peptides. His work focuses on addressing behavioral abnormalities associated with various cognitive disorders.
Latest Patents
Schwartz-Eisenbach holds a patent for "Modified kisspeptin peptides and uses thereof." This patent provides synthetic modified peptides composed of five to seven natural or non-natural amino acids. The pharmaceutical compositions derived from these peptides are intended for the treatment of diseases or disorders that present behavioral abnormalities, such as schizophrenia and Alzheimer's disease.
Career Highlights
He is affiliated with Yeda Research and Development Co. Ltd., where he continues to advance his research. His innovative approach to peptide synthesis has opened new avenues for therapeutic interventions in mental health.
Collaborations
Some of his notable coworkers include Matityahu Fridkin and Michal Cardon-Yaakov, who contribute to the collaborative research environment at Yeda.
Conclusion
Michal Schwartz-Eisenbach's work in peptide research exemplifies the potential of innovative therapies for cognitive disorders. His contributions are paving the way for future advancements in the treatment of complex behavioral conditions.